Though ADHD is typically treated with stimulants like Adderall, people may opt for non-stimulants because they come with ...

Attention-deficit hyperactivity disorder (ADHD) medications are prescribed to manage common ADHD symptoms, like difficulty focusing, impulsiveness, and hyperactivity. Medications approved to treat ...

Contrary to popular belief, non-stimulant ADHD medications (atomoxetine and viloxazine) affect heart rate and blood pressure just as much as stimulants do. All ADHD medications except guanfacine ...

Pharmaceutical companies would be wise to pay attention to developing new treatments for ADHD as there is a demand for improved drugs in the space. Though there are non-stimulant drugs on the market ...

The centrally acting alpha2-adrenergic agonist is approved for patients 6 years of age and older. HealthDay News — The US Food and Drug Administration has approved once-daily Onyda XR (clonidine ...

MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and ...

MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and ...

We both treat ADHD patients with medication, and we are used to drug company representatives trying to show us the “latest and greatest” pharmaceutical innovation for ADHD. Unfortunately as noted in ...

Attention-deficit/hyperactivity disorder (ADHD), which causes affected individuals to be impulsive, hyperactive, or inattentive, is typically treated with medications ...

A recent study that included 148,000 people diagnosed with attention deficit hyperactivity disorder (ADHD) found that taking prescribed ADHD medications was linked to lower rates of premature deaths ...